National University of Singapore: Drugs Used to Treat Blood Cancer Could Activate 'Sleeping' Cancer-Causing Gene
May 27, 2022
May 27, 2022
SINGAPORE, May 27 (TNSjou) -- The National University of Singapore issued the following news release:
* * *
Scientists suggest an approach for early intervention to improve treatment outcome
* * *
Hypomethylating agents (HMA) are currently used as a first-line treatment for patients with myelodysplastic syndrome (MDS) - a group of disorders where there is insufficient production of healthy mature blood cells in the bone marrow - and increasingl . . .
* * *
Scientists suggest an approach for early intervention to improve treatment outcome
* * *
Hypomethylating agents (HMA) are currently used as a first-line treatment for patients with myelodysplastic syndrome (MDS) - a group of disorders where there is insufficient production of healthy mature blood cells in the bone marrow - and increasingl . . .